Search results
Showing 946 to 960 of 2042 results for guidelines
In development [GID-TA11408] Expected publication date: TBC
Evidence-based recommendations on laparoscopic laser myomectomy. This involves passing a fine telescope (laparascope) through small cuts in the abdomen and uterus wall, and using a laser to destroy the fibroids.
View recommendations for IPG23Show all sections
Antimicrobial prescribing: eravacycline for complicated intra-abdominal infections in adults (ES40)
Summary of the evidence on eravacycline for complicated intra-abdominal infections in adults
In development [GID-TA10877] Expected publication date: 08 January 2025
officer, deputy chief executive and interim director of the centre for guidelines) Consultant in emergency medicine, University...
officer, deputy chief executive and interim director of the centre for guidelines) Consultant in emergency medicine, University...
officer, deputy chief executive and interim director of the centre for guidelines) Consultant in emergency medicine, University...
Non-Hodgkin's lymphoma: rituximab subcutaneous injection (ESNM46)
Summary of the evidence on rituximab subcutaneous injection for non-Hodgkin's lymphoma in adults to inform local NHS planning and decision-making
Any explanatory notes(if applicable) Why this is important:- Guidelines from many countries have said that muscle relaxants should be...
Benefits of working at NICE
assessment, monitoring and treatment is provided. The NICE quality standard and guideline on antenatal and postnatal mental health state...
guide, for example for doctors the General Medical Council's good practice guidelines . These include giving information about the...
Diabetes: blood pressure (without moderate or severe frailty) (IND249)
This indicator covers the percentage of patients with diabetes on the register, aged 79 years and under without moderate or severe frailty, in whom the last blood pressure reading (measured in the preceding 12 months) is less than 135/85 mmHg if using ambulatory or home monitoring, or less than 140/90 mmHg if measured in clinic. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM233
Woundchek Protease Status for assessing elevated protease status in chronic wounds (MIB83)
NICE has developed a medtech innovation briefing (MIB) on the Woundchek Protease Status for assessing elevated protease status in chronic wounds .
MR-proADM test for use with clinical deterioration scores in cases of suspected infection (MIB195)
NICE has developed a medtech innovation briefing (MIB) on the MR-proADM test for use with clinical deterioration scores in cases of suspected infection .